Article Details

Enteris BioPharma Announces Successful Completion of Phase 1 Clinical Trial of Optimized ...

Retrieved on: 2021-10-04 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Enteris BioPharma Announces Successful Completion of Phase 1 Clinical Trial of Optimized .... View article details on hiswai:

Excerpt

Enteris BioPharma, Inc. is a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH) offering total integrated contract development and manufacturing ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up